Nobuhiro Tanuma
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
The iron-sulfur cluster assembly factor FDX2 is required for tumor initiation but not for growth of established tumors in transplantation models.
Journal: The Journal of biological chemistry
Published: October 10, 2025
Targeting NAD metabolism in neuroendocrine carcinoma
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: July 02, 2025
FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells.
Journal: The Journal of biological chemistry
Published: April 17, 2024
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma.
Journal: Nature communications
Published: April 18, 2023
Robustness of a Cancer Profiling Test Using Formalin-fixed Paraffin Embedded Tumor Specimens.
Journal: Anticancer research
Published: December 28, 2020
Ppp6c deficiency accelerates K-rasG12D -induced tongue carcinogenesis.
Journal: Cancer medicine
Published: December 07, 2020
Dietary intervention as a therapeutic for cancer.
Journal: Cancer science
Published: November 03, 2020
Ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
Journal: Cancer science
Published: October 16, 2020
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: July 22, 2020
Last Updated: 09/26/2026